DE GRAAFF WOUTER,VEENSTRA HARM,MULDERS TITIA MARTINE TRUCE
申请号：
IN8372/DELNP/2011
公开号：
IN2011DN08372A
申请日:
2011.10.28
申请国别(地区):
IN
年份:
2013
代理人:
摘要：
An intrauterine system (1) is disclosed for use in the treatment of dysfunctional uterine bleeding menorraghia dysmenorrhoea endometriosis uterine fibroids climacteric complaints osteoporosis and urogenital atrophy. The system is formed by a frame (16) defining an interior space (20) for receipt of a deposit (22) of a therapeutically effective dose of a biologically active compound. The frame has an open structure allowing access to a substantial part of an outer surface of the deposit, and the deposit has a rate controlling structure (26) that controls a rate of release of the compound within the uterus. One or more retention elements (6) are provided on the frame for retaining the frame within the uterus of a female mammal.
